LBRX EBITDA Growth

Lb Pharmaceuticals Inc · EBITDA Growth

LBRX logo

LBRX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-69.67%
LBRX TTM EBITDA YoY % (37.61% → -69.67%)
High-resolution chart · PNG

LBRX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Lb Pharmaceuticals Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-69.669%
37.6112%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.